லாரா என்சைன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from லாரா என்சைன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In லாரா என்சைன் Today - Breaking & Trending Today
Bayer extends research agreement with Hopkins through 2024 The pharmaceuticals and life sciences company will continue its partnership with Johns Hopkins to provide funding to researchers in the Wilmer Eye Institute Credit: Wikimedia Commons May 6, 2021 The Johns Hopkins University and Bayer AG have extended their strategic research alliance in ophthalmology through the end of 2024. The agreement will provide multimillion-dollar funding for researchers at the Johns Hopkins Wilmer Eye Institute to pursue treatments for a variety of eye diseases and ailments while benefitting from the expertise of Bayer scientists about potential drug candidates. A drug candidate from one of the collaboration s programs has advanced to a phase II clinical trial and another program is licensed to a startup company. Researchers on both sides hope to translate the joint research into improved vision by moving innovative treatments from labs to patients eyes. ....
In a study in mice and human cells, Johns Hopkins Medicine researchers say that they have developed a tiny, yet effective method for preventing premature birth. The vaginally delivered treatment contains nanosized (billionth of a meter) particles of drugs that easily penetrate the vaginal wall to reach the uterine muscles and prevent them from contracting. If proven effective in humans, the treatment could be one of the only clinical options available to prevent preterm labor. The FDA has recommended removing Makena (17-hydroxyprogesterone caproate), the only approved medicine for this purpose, from the market. The study was published Jan. 13, 2020, in the journal ....
In a study in mice and human cells, Johns Hopkins Medicine researchers say that they have developed a tiny, yet effective method for preventing premature birth. ....
E-Mail In a study in mice and human cells, Johns Hopkins Medicine researchers say that they have developed a tiny, yet effective method for preventing premature birth. The vaginally-delivered treatment contains nanosized (billionth of a meter) particles of drugs that easily penetrate the vaginal wall to reach the uterine muscles and prevent them from contracting. If proven effective in humans, the treatment could be one of the only clinical options available to prevent preterm labor. The FDA has recommended removing Makena (17-hydroxyprogesterone caproate), the only approved medicine for this purpose, from the market. The study was published Jan. 13 in Science Translational Medicine. ....